The Lunenfeld-Tanenbaum Research Institute
Donate Now - Mount Sinai Hospital Foundation of Toronto Lunenfeld QR code
Personal tools
Dr. Robert Casper
Home Researchers Dr. Robert Casper

Dr. Robert Casper

casper  

Dr. Robert Casper

SENIOR INVESTIGATOR

Dr. Bob Casper has given many couples new hope for a healthy pregnancy. As a leader in fertility treatment and Medical Director for the Toronto Centre for Advanced Reproductive Technology - the leading research-based facility in Canada - Dr. Casper has won international recognition for his research and patient care.

Dr. Casper's research led to the development of a new treatment, originally approved for the treatment of breast cancer, for ovulation  stimulation in infertile women that doubles a patient's chances of pregnancy compared to older treatment. He is also leading research in endometriosis - one of the most common causes of pelvic pain and infertility in women - and is developing a genetic test that would detect young girls at risk of the disease, allowing for preventative treatment.

Interested by innovation and new ideas, Dr. Casper has also initiated studies in melatonin production in night shift workers. Melatonin has been shown to be an anti-cancer hormone and decreased levels have been connected to increased incidence of prostate, colon and breast cancers in shift workers. After studying the impact of light wavelengths on melatonin during peak production hours, Dr. Casper has proposed a new device that would protect individuals from depleted melatonin levels and reduce risk of cancer, as well as preventing depression and diabetes.

Dr. Casper is also doing exciting work in cord blood banking and in research to extend the medical applications of banked cord blood samples. He founded Canada's first cord blood bank at Mount Sinai Hospital, and as Scientific Director of Insception Biosciences (the company now leading the program) he continues to play a key role in cord blood banking and stem cell research.

Finally, Dr Casper is studying the possibility of reducing the risk of breast cancer in menopausal women on hormone replacement therapy by the addition of an aromatase inhibitor.   

Lunenfeld-Tanenbaum
Research Institute
Mount Sinai Hospital
Joseph and Wolf Lebovic Health Complex
600 University Avenue
Toronto Ontario M5G 1X5

Tel: 416-586-4800 ext.2053
► Send Email

 

 

At a Glance

  • Dr. Robert Casper leads research on fertility and endometriosis and also studies stem cells, shift work and cancer risk
  • He holds the Camille Dan Family Research Chair in Translational Cell Biology
  • He established Canada's first cord blood bank at Mount Sinai Hospital
  • His research has led to the development of a new treatment for ovulation induction that doubles a patient's chances of pregnancy compared to previous treatments, and he has developed an experimental technique that improves embryo development under in vitro conditions
  • Did you know...? It's estimated that 1 in 6 Canadian couples are infertile
  • Dr. Casper has also developed special glasses for night shift workers - the glasses that block out the blue range of light and prevent disruptions in biological rhythms

 

Major Research Activities

The Casper lab undertakes a number of major areas of research aimed at improving clinical practice and patient care. One is the investigation of the role of mitochondrial mutation in oocyte aging. The lab also focuses on the in vitro expansion of human umbilical cord blood stem cells and their use for tissue therapeutics. The third area of research is the use of aromatase inhibitors for induction of ovulation and for improving implantation in assisted reproductive technology.

 

Recent Publications

 

Document Actions
Ontario Health Study Faculty of Medicine, University of Toronto. mitacs honorary partner

 

 
plone
       
 
   
spinner
Facebook popup Youtube popup Twitter popup RSS popup